Analytical performance of the IDS-iSYS N-Mid osteocalcin immunoassay by GADISSEUR, Romy et al.
Analytical Performance of the 
IDS-iSYS N-Mid Osteocalcin Immunoassay
Romy Gadisseur, Pierre Lukas, Agnès Carlisi, Etienne Cavalier
Department of Clinical Chemistry, University of Liège, CHU Sart-Tilman, Liège, Belgium
Background
Serum osteocalcin, also known as bone Gla protein, is a marker of bone turnover with short half-life and is hydrolyzed in the kidney and liver.  Osteocalcin 
is a 49-residue (5.8 kDa) polypeptide; the C-terminal fragment is easily cleaved and the N-terminal mid-fragment shows greater stability.  Immunoassays 
detecting only intact osteocalcin will be particularly sensitive to samples degradation; assays detecting fragments may, depending on the fragments 
recognized, overestimate the concentrations of intact osteocalcin.  The intact molecule and the N-terminal fragment are the most abundant immunoreactive 
forms in healthy and osteoporotic patients. We reported the analytical performance of the automated IDS-iSYS N-Mid Osteocalcin assay. 
Materials and Methods
The precision profile was determined with 11 serum pool levels (0.5 - 177.5 ng/mL). The linearity was verified with two sets of high/low serum samples. 
Over 200 serum samples were used for the method comparison between three N-Mid Osteocalcin assays: IDS-iSYS versus the IDS ELISA (n = 263,       
1.9 – 176.2 ng/mL) and the IDS-iSYS versus Roche Elecsys (n = 208, 3.0 – 142.2 ng/mL). 
Results
Fig.1: IDS-iSYS N-MID Osteocalcin 
precision profile. 
The precision profile of  11 serum 
pools (0.5 - 177.5 ng/mL) ranged from 
1.6 to 42%. The assay’s LoQ was 
confirmed as 1.5 ng/mL. 
Fig. 3: Method comparison 
Passing Bablok regression plot 
between IDS ELISA and IDS-iSYS 
(n = 263). 
We observed excellent correlation  
regression slope (95% Cl.) was 
1.03(1.00 to 1.07) with   correlation 
(r) of  0.995 (0.994 to 0.996). 
Conclusion
?Our data shows that the fully automated IDS-iSYS N-MID Osteocalcin method offers a reliable alternative method for osteocalcin blood test.
?We verified the manufacturer’s claims of Limit of Quantitation (LoQ) , precision, linearity and assay measurable range.  
?The IDS-iSYS N-Mid Osteocalcin gave similar results to two other FDA 510(k) cleared N-Mid Osteocalcin immunoassays. 
?This automated assay demonstrated suitable characteristics as a high throughput bone turnover assay for clinical laboratories
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Precision profile Linearity profile IDS ELISA versus IDS-iSYS Elecsys versus IDS-iSYS
Fig.2: IDS-iSYS N-MID Osteocalcin 
linearity profile. 
The linear regression of  high/low 
serum samples dilutions (n=18) was: 
Observed = 0.96 x (Expected) + 3.4;
R2 =  0.997 
Fig. 4: Method comparison 
Passing Bablok regression plot 
between Roche Elecsys and     
IDS-iSYS (n = 208). 
Good correlation obtain when 
measuring 208 serum samples in 
two fully automated N-MID 
Osteocalcin kits, Elecsys and       
IDS-iSYS. correlation  regression 
slope (95% Cl.) was 0.92 (0.89 to 
0.94) with   correlation (r) of  0.988 
(0.981 to 0.989).  
